Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
Clinical trial NCT00369226 · COMPLETED
Trial details
- NCT number
- NCT00369226
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2010-07-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.